Cardiometabolic Health Congress (CMHC)
K

DKD & SGLT-2 Inhibitors: Can They Reduce Risks of Albuminuria, eGFR Decline, ESKD, HF, and CVD in Non-Diabetic/T2D Patients?

By Cardiometabolic Health Congress (CMHC) FEATURING Katherine R. Tuttle
By Cardiometabolic Health Congress (CMHC) FEATURING Katherine R. Tuttle
765 views
January 15, 2021
1 Comment
Login to view comments. Click here to Login

Featured Video

15:01
Lilly Diabetes

Discover the MOA of an Incretin Medication for T2D

Featured Video

15:01
Lilly Diabetes

Discover the MOA of an Incretin Medication for T2D

Related Content

AUTOPLAY
Medical College of Georgia - Augusta University

Seizure, Spells and Shakes: Neurology for the Non-Neurologist

Wed, Jul 10, 2024
See 1 other
06:38
Allan Jaffe

What Does Elevated Troponin Mean in COVID-19?

47:11
Houston Methodist Hospital

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
49:21
Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key
23:10
Jefferson Health

Proton Pump Inhibitors in 2024: The Pros, the Cons and the Truth

Feat. P. Wong
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
23:35
Practical Ways to Achieve Targets in Diabetes Care

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Feat. I. Hirsch
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
21:46
PKD Foundation

Genetic Testing in PKD

Feat. N. Dahl, K. Kolbert
27:14
MUSC Cardiology

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

Feat. R. Mentz
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
25:21
Congenital and Structural Interventions

LAA Closure for Atrial Fibrillation using Occlusion Device

Feat. H. Sievert
42:46
PKD Foundation

Basics of Clinical Care for Children with ARPKD and ADPKD

Feat. L. Guay-Woodford
26:49
Diana Isaacs

Tirzepatide Updates